STA
THTX

Summit Trail Advisors’s Theratechnologies THTX Stock Holding History

Summit Trail Advisors’s Portfolio THTX Stock Details THTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-33,090
Closed -$46.3K – 1144
2025
Q1 		$46.3K Hold
33,090
– – ﹤0.01% 417
2024
Q4 		$59.9K Hold
33,090
– – ﹤0.01% 387
2024
Q3 		$41K Hold
33,090
– – ﹤0.01% 714
2024
Q2 		$46.3K Hold
33,090
– – ﹤0.01% 608
2024
Q1 		$54.9K Buy
+33,090
New +$53.1K ﹤0.01% 593

Other funds holding THTX

SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
AIMCA
Alberta Investment Management Corp (AIMCo) Edmonton, Alberta, Canada $16.7B AUM 23.27% 1-Year Est. Return
Skandinaviska Enskilda Banken (SEB)
Skandinaviska Enskilda Banken (SEB) Stockholm, Sweden $4.34B AUM 19.31% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
HI
Harbour Investments Madison, Wisconsin $6.48B AUM 18.23% 1-Year Est. Return

Summit Trail Advisors's THTX Position: Q2 2025 in Review

Summit Trail Advisors sold out of Theratechnologies (THTX) in Q2 2025, closing a stake of 33,090 shares — an estimated $46.3K sold.

Summit Trail Advisors first reported a position in THTX in Q1 2024 and held it in 5 quarters. The position peaked at $59.9K in Q4 2024. 49 funds tracked by Wall St. Rank hold THTX as of Q2 2025.

  • Summit Trail Advisors reported no remaining Theratechnologies position as of Q2 2025 after selling out during the quarter.
  • Summit Trail Advisors sold 33,090 Theratechnologies shares in Q2 2025, an estimated $46.3K.
  • Summit Trail Advisors first reported a position in Theratechnologies in Q1 2024 and held it in 5 quarters.
  • Summit Trail Advisors's Theratechnologies position peaked at $59.9K in Q4 2024.
  • 49 funds tracked by Wall St. Rank held Theratechnologies as of Q2 2025.

Based on Summit Trail Advisors's 13F filing for Q2 2025, filed 14 Aug 2025.